BIG PHARMA EARNINGS WATCH: NOVARTIS, ELI LILLY & ROCHE

Trio of Big Pharma Firms Bank Q1 Profits Driven By Price Hikes New first Read More

CSRXP APPLAUDS PRESIDENT BIDEN’S CALL FOR BIPARTISAN SOLUTIONS TO LOWER DRUG PRICES

Administration and Congress Must Work Together To Pass Solutions to Hold Big Read More

CSRXP: TIME FOR POLICYMAKERS TO DELIVER ON AMERICANS’ CALL TO LOWER OUT-OF-CONTROL DRUG PRICES

Holding Big Pharma Accountable Remains Top Priority for American Voters Read More

CSRXP: HR3 REINTRODUCTION ADDS TO MOMENTUM FOR D.C. TO LOWER DRUG PRICES, HOLD BIG PHARMA ACCOUNTABLE

Congress and the Administration Must Act on Solutions that Have Won Bipartisan Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

Drug Company Banks Expectation-Busting Profits for Q1 While Continuing to Hike Read More

ICYMI: AMERICANS NEED RELIEF FROM BIG PHARMA’S OUT-OF-CONTROL PRESCRIPTION PRICES

Americans Need Relief from Big Pharma’s Out-of-Control Prescription Prices Read More

DOSE OF REALITY: BIG PHARMA’S PRICING PRACTICES DRIVE CRISIS OF AFFORDABILITY FOR AMERICA’S CANCER PATIENTS

Drug Companies Repeatedly Hike Prices and Set Out-of-Control Launch Prices on Read More

SECOND OPINION: DEBUNKING BIG PHARMA’S NEW BRANDING CAMPAIGN

PhRMA Proposals Fail to Lower Rx Prices and Instead Benefit Drug Companies and Read More

CSRXP LAUNCHES CAMPAIGN ENCOURAGING POLICYMAKERS TO KEEP THEIR PROMISE TO LOWER RX PRICES

Campaign Will Highlight Impact of Out-of-Control Drug Prices, Especially in Read More

BOLDY BOGUS: CBO UNDERMINES BIG PHARMA’S INNOVATION RHETORIC

Government Report Finds No Relationship Between Drug Company R&D and Read More